The Citric Acid Cycle
The Citric Acid Cycle: Harvesting Electrons
The citric acid cycle makes almost no ATP itself, just one GTP per turn. Its real product is high-energy electrons — three NADH and one FADH2 per acetyl-CoA — carried off to the electron transport chain where most of the cell's ATP is actually minted. Watch one carbon, count the cofactors, and notice that oxaloacetate comes out of every turn exactly as it went in: the cycle is a catalyst, not a fuel, which is the single fact most students get wrong.
Glycolysis handed off two pyruvates and warned us the real bottleneck was NAD⁺. The citric acid cycle is where that warning comes due. Almost every student arrives believing this cycle’s job is to make ATP. It is not. Per turn, the cycle makes exactly one high-energy phosphate. Its actual product is electrons — three NADH and one FADH₂ — which it ships to the electron transport chain, where the bulk of your ATP is finally minted. Get that one reframe and the whole chapter clicks: the citric acid cycle harvests electrons; the ETC spends them.
The cycle’s real job is to harvest electrons
Think of NADH and FADH₂ as rechargeable batteries. The cycle’s eight enzymes pry high-energy electrons off carbon and load them onto these carriers. The electron transport chain then drains the carriers, handing NAD⁺ and FAD back to be charged again, and oxygen keeps that going by accepting the spent electrons at the very end. This is why a favorite trick question — is O₂ a substrate of the citric acid cycle? — has the answer no. Look at all eight reactions and you will not find oxygen in any of them. O₂ is still absolutely required, but only indirectly: without it the ETC cannot regenerate NAD⁺, and the cycle runs out of empty batteries and stalls within seconds. That distinction, required but not a substrate, is worth more than any mnemonic.
The bookkeeping for one acetyl-CoA is clean and worth memorizing: 3 NADH, 1 FADH₂, 1 GTP, 2 CO₂. The two carbons that leave as CO₂ are the carbons being oxidized; the electrons stripped off them are the prize.
Oxaloacetate is a catalyst, not a fuel
Here is the misconception that sinks more exam answers than any other: students picture the cycle getting “used up,” as if oxaloacetate were burned away. It is not. Oxaloacetate (OAA) enters step 1, runs all the way around, and is regenerated unchanged at step 8. A single OAA molecule can run thousands of turns. The fuel that gets consumed is acetyl-CoA, fed in fresh each turn; OAA is the reusable platform the cell builds each acetyl group onto.
Krebs learned to look for exactly this kind of molecule from his earlier work on the urea cycle — find the thing that comes out unchanged, and you have found the catalyst at the heart of a cycle. Tap through the eight steps below and watch the tally climb to 3 NADH + 1 FADH₂ + 1 GTP, or press “Turn the whole cycle” to reveal them all at once. Step 8 hands back the oxaloacetate that step 1 consumed. That regeneration is the catalytic payoff.
regulated step
The condensation that starts the turn. 'Synthase' means no ATP is spent: the energy comes from cleaving acetyl-CoA's high-energy thioester. Ordered induced fit, with the citryl-CoA intermediate hydrolyzed while still bound so the thioester energy is not wasted. The most exergonic step (ΔG°′ ≈ −31.4 kJ/mol, standard free energy), effectively irreversible — the committed step that pulls the whole cycle forward.
Clinical. Because it consumes oxaloacetate, this step drives the otherwise-unfavorable malate→oxaloacetate step (8) forward: the cycle's reactions are coupled, not independent.
An isomerization, not a redox step: a dehydration then a rehydration moves the hydroxyl from a tertiary, un-oxidizable carbon to a secondary one so step 3 can oxidize it. Uses a [4Fe-4S] iron–sulfur cluster to position the substrate.
Clinical. Fluoroacetate (a rodenticide from Australian Gastrolobium plants) is converted in the cell to fluorocitrate, a suicide inhibitor that jams aconitase and backs up citrate — one of Krebs's diagnostic poisons.
First oxidative decarboxylation: oxidize, then lose CO₂ (via a bound oxalosuccinate intermediate), banking NADH #1. A principal flux-controlling step and the cycle's primary throttle — distinct from the committed step (citrate synthase), which provides the thermodynamic pull.
Clinical. Mutant IDH (in gliomas and AML) gains a new activity, making the oncometabolite 2-hydroxyglutarate, which scrambles DNA and histone methylation. IDH inhibitors are now approved drugs.
Second oxidative decarboxylation, banking NADH #2 and the cycle's second CO₂. Mechanistically the twin of pyruvate dehydrogenase: E1/E2/E3 with five cofactors and substrate channeling. Both acetyl carbons have now, formally, balanced out as CO₂.
Clinical. A second control point: inhibited by its products NADH and succinyl-CoA, activated by Ca²⁺ during exercise.
The only substrate-level phosphorylation in the cycle. Cleaving succinyl-CoA's thioester drives GDP→GTP (ATP in some tissues) through a phosphohistidine enzyme intermediate. The cycle's lone direct high-energy phosphate.
Clinical. 'Synthetase' (uses/forms a nucleotide triphosphate) versus 'synthase' (step 1, none): the naming tells you whether nucleotide energy is involved.
The only membrane-bound step — it IS Complex II of the electron-transport chain, embedded in the inner membrane and feeding electrons straight into the chain. FAD is used instead of NAD⁺ because oxidizing a C–C single bond releases too little energy for NAD⁺. Note: succinate is itself symmetric, so from here on the two original acetyl carbons can no longer be told apart.
Clinical. Competitively inhibited by malonate (succinate minus one CH₂), a classic traffic jam. SDH loss-of-function mutations cause paragangliomas, with succinate acting as an oncometabolite.
A stereospecific hydration that adds water across the double bond to make only L-malate. Fumarate, like succinate before it, is symmetric, so carbon tracking from here is by reasoning, not memorization.
Clinical. Fumarate hydratase mutations cause hereditary leiomyomatosis and renal cell cancer; accumulated fumarate is an oncometabolite.
Regenerates oxaloacetate and banks NADH #3, closing the ring. In isolation this step is strongly unfavorable (very positive ΔG°′), but citrate synthase immediately consumes oxaloacetate, pulling it forward — the catalyst is restored and the next turn begins.
Clinical. Oxaloacetate comes out exactly as it went in: the cycle is a catalyst, not a fuel. That is the whole point.
Burn the fuel, then rebuild the machine
The cleanest way to hold eight enzymes in your head is to see the cycle as a two-stage factory. Picture a fireplace: Stage One burns the firewood down to CO₂, and Stage Two sweeps the ashes into a new fireplace so you can burn again.
Stage One — the furnace (steps 1–4) burns the two acetyl carbons to two CO₂ and banks 2 NADH.
1 · Citrate synthase condenses 4-carbon OAA with 2-carbon acetyl-CoA into 6-carbon citrate. Note the name: a synthase uses no ATP; the energy comes from cleaving acetyl-CoA’s high-energy thioester. (Contrast a synthetase, whose name tells you a nucleotide triphosphate is involved; you will meet one at step 5, running in the direction that makes GTP.)
2 · Aconitase isomerizes citrate to isocitrate, simply relocating a hydroxyl group so it can be oxidized — no redox here.
3 · Isocitrate dehydrogenase performs the first oxidative decarboxylation, releasing CO₂ #1 and NADH #1. This is the rate-limiting step and the cycle’s main throttle.
4 · The α-ketoglutarate dehydrogenase complex performs the second, releasing CO₂ #2 and NADH #2. That complex is the structural and mechanistic twin of pyruvate dehydrogenase — same E1/E2/E3 architecture, same five cofactors (TPP, lipoic acid, CoA, FAD, NAD⁺), same substrate channeling that tunnels intermediates from one active site to the next without ever letting them diffuse free.
Stage Two — the rebuilding crew (steps 5–8) regenerates OAA and banks 1 GTP, 1 FADH₂, and 1 NADH.
5 · Succinyl-CoA synthetase is the cycle’s lone substrate-level phosphorylation: cleaving succinyl-CoA’s thioester drives GDP to GTP through a phosphohistidine intermediate.
6 · Succinate dehydrogenase is the odd one out — it sits in the inner mitochondrial membrane and is Complex II of the ETC, feeding electrons straight into the chain. It uses FAD instead of NAD⁺ because oxidizing a plain C–C bond yields too little energy for NAD⁺.
7 · Fumarase hydrates fumarate to L-malate.
8 · Malate dehydrogenase regenerates OAA with NADH #3, closing the ring. That last step is unfavorable in isolation, but citrate synthase devours OAA the instant it appears, pulling the reaction forward. The steps are coupled, not independent.
Where memorization fails and reasoning begins
Trace a labeled carbon and something surprising happens. The four-carbon intermediate becomes symmetric at succinate, so from there on the cell cannot tell the two ends apart. The carbons that leave as CO₂ in any given turn are not the carbons that just entered as acetyl-CoA; those entering carbons stay in the molecule and only exit on later turns. You cannot brute-force this with memory; you have to reason about symmetry. In the carbon tracker below, the two acetyl carbons are orange. Step forward to succinate and all four carbons turn half orange, half navy: that is where the label scrambles and the bookkeeping stops being trivial.
The net is honest — two carbons in as acetyl-CoA, two out as CO₂. But in this one turn the CO₂ comes from oxaloacetate, while your labeled acetyl carbons stay in the molecule. Only after succinate's symmetry scrambles them, over later turns, do they leave. This is the classic isotope-labeling result, and the reason "two in, two out" is true on the books but misleading atom-by-atom.
The throttle: ATP says stop, ADP and calcium say go
The cell is financially literate, and it regulates the cycle by reading its own energy charge. The two control points are the two irreversible oxidative decarboxylations: isocitrate dehydrogenase and α-ketoglutarate dehydrogenase. The rule is simple: ATP and NADH = STOP (the cell is rich, no need to burn more), ADP, NAD⁺, and Ca²⁺ = GO. Calcium is the exercise signal — when a muscle contracts, the same Ca²⁺ released to drive contraction directly activates the cycle, matching fuel-burning to demand. Pyruvate dehydrogenase gates entry upstream by the same logic.
Amphibolic, anaplerotic, and clinical
The cycle is amphibolic: it serves both catabolism and anabolism. It burns fuel, and its intermediates are siphoned off to build things: citrate exports for fatty-acid synthesis, α-ketoglutarate becomes glutamate and other amino acids, succinyl-CoA builds heme, and OAA feeds gluconeogenesis. Drain intermediates and you would deplete OAA, so the cell refills it by anaplerosis — chiefly pyruvate carboxylase, which adds CO₂ to pyruvate to make OAA and is switched on by acetyl-CoA in a smart feedforward signal (“fuel is arriving; build more of the platform”).
The clinical payoffs are striking. Mutations in succinate dehydrogenase and fumarase let succinate and fumarate pile up as oncometabolites that drive paragangliomas and kidney cancer; mutant isocitrate dehydrogenase makes 2-hydroxyglutarate, scrambling the epigenome in gliomas and leukemias, and IDH inhibitors are now real drugs. The Warburg effect, in which tumors run glycolysis hard even with oxygen available, is a related rewiring at the cycle’s entrance: pyruvate is turned into lactate instead of entering the cycle as acetyl-CoA.
The ATP math, and what comes next
Now cash the batteries. Each NADH is worth about 2.5 ATP at the ETC, each FADH₂ about 1.5, and the GTP counts as one: 3×2.5 + 1×1.5 + 1 ≈ 10 ATP per acetyl-CoA, which works out to roughly 30–32 ATP per glucose once you add glycolysis and pyruvate oxidation. But notice — almost none of that ATP was made here. The cycle’s job was to fill the carriers. Cashing them is the subject of the next chapter, oxidative phosphorylation and the electron transport chain, where oxygen finally takes the stage.
How we measure it
Warburg manometry (respirometry)
A sealed flask on a manometer measures the gas a tissue exchanges — O2 consumed, CO2 released — in real time. Krebs used minced pigeon-breast muscle on Warburg's manometer to watch respiration speed up when he added an intermediate, the assay that built the cycle. Its modern descendant is the Seahorse analyzer, which reads cellular oxygen consumption to fingerprint mitochondrial function.
Selective enzyme inhibition (pathway dissection)
Jam one step with a specific poison, then see which intermediate floods and which runs dry — that pattern reveals the order of the steps. Malonate blocks succinate dehydrogenase and backs up succinate; fluoroacetate blocks aconitase and backs up citrate. This 'poison and watch the traffic jam' logic is exactly how Krebs proved the sequence was a cycle.
Isotopic carbon tracking
Label a carbon with ¹³C or ¹⁴C and trace where it lands turn by turn. This is the only way to see that the carbons leaving as CO2 in one turn are not the carbons that just entered — and that after succinate the molecule becomes symmetric, so the two ends become indistinguishable. It turns 'memorize the cycle' into 'reason about the cycle.'